Pleural Effusion Secondary to Multiple Myeloma. Is Daratumumab an Effective Treatment? A Case Report-Reference-Cited by-同舟云学术

Pleural Effusion Secondary to Multiple Myeloma. Is Daratumumab an Effective Treatment? A Case Report

Published:2021-01-26 Issue: Volume: Page:
ISSN:
Container-title:Multiple Myeloma [Working Title]
language:
Short-container-title:

Author:

Plazzo Giulia,Aprile Lara,Cecere Giacomo,Pier Gagliardi Vito,Maggi Alessandro,Prudenzano Antonella,Mazza Patrizio

Abstract

Extramedullary Plasmacytoma (EM) disease is an aggressive presentation at diagnosis and relapse for multiple myeloma (MM) patients. EM plasmacytoma is divided into two groups: the first group comprises tumors that are extending directly from osteolytic bone lesions while the second results from plasmacytoma infiltration into soft tissues, with no relationship to the bone. Despite new therapies and monoclonal antibodies the survival for patients with EM plasmocytoma is poor. The involvement pleural is uncommon in Multiple Myeloma.

Publisher

IntechOpen

Link

http://www.intechopen.com/download/pdf/74929

Reference5 articles.

1. Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, Haydaroglu A. A Review for Solitary Plasmacytoma of Bone and Extramedullary Plasmacytoma. The Scientific World Journal [Internet]. Hindawi Limited; 2012;2012:1-6. Available from: http://dx.doi.org/10.1100/2012/895765

2. Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica [Internet]. Ferrata Storti Foundation (Haematologica); 2007 Jan 1;92(1):50-5. Available from: http://dx.doi.org/10.3324/haematol.10554

3. Van Lammeren-Venema D, Regelink JC, Riphagen II, Zweegman S, Hoekstra OS, Zijlstra JM. 18F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: A systematic review. Cancer [Internet]. Wiley; 2011 Sep 1;118(8):1971-81. Available from: http://dx.doi.org/10.1002/cncr.26467

4. Dingli D, Ailawadhi S, Bergsagel PL, Buadi FK, Dispenzieri A, Fonseca R, et al. Therapy for Relapsed Multiple Myeloma. Mayo Clinic Proceedings [Internet]. Elsevier BV; 2017 Apr;92(4):578-98. Available from: http://dx.doi.org/10.1016/j.mayocp.2017.01.003

5. Husnain M, Kurtin S, Barkett N, Riaz IB, Agarwal A. Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review. Case Reports in Oncological Medicine [Internet]. Hindawi Limited; 2016;2016:1-4. Available from: http://dx.doi.org/10.1155/2016/2490168

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelomatous pleural effusion developing after autologous stem cell transplantation in a patient with multiple myeloma: A rare case;Indian Journal of Pathology and Microbiology;2022-10-18

2. Multiple muscle involvement in relapsed multiple myeloma: A rare case;Journal of Cancer Research and Therapeutics;2022